Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accounts payable and other liabilities | (4,804) | (8,601) |
| Net cash used in operating activities | (144,922) | (105,893) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (221) | (981) |
| Purchases of marketable securities | (64,278) | (65,970) |
| Maturities of marketable securities | 33,459 | 65,439 |
| Sales of marketable securities | 28,648 | 2,970 |
| Net cash used in investing activities | (2,392) | 1,458 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s capex?
- Dyne Therapeutics, Inc. (DYN) reported capex of $221K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s capex changed year-over-year?
- Dyne Therapeutics, Inc.'s capex decreased by 77.5% year-over-year, from $981K to $221K.
- What is the long-term trend for Dyne Therapeutics, Inc.'s capex?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s capex has grown at a -14.6% compound annual growth rate (CAGR), from $3.62M to $1.92M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Dyne Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude